Clinical Trial Update: Preventive Approach Using Venlafaxine [Phase 4]

View source ↗

Summary

Phase 4 clinical trial exploring a preventive approach using venlafaxine for chemotherapy-induced peripheral neuropathy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Neuropathy Due to Chemotherapy

Drugs mentioned

• Venlafaxine (Venlafaxine)

Snippet

Sponsor: Mit Ghamr Oncology Center | Conditions: Peripheral Neuropathy Due to Chemotherapy | Phase 4 | Status: UNKNOWN